Eli Lilly stock enters weekly review with 21 dermatology presentations
Published on 10/10/2026 at 11:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- Eli Lilly announced 21 dermatology presentations for Fall Clinical 2026.
- The company highlighted EBGLYSS, Taltz, Zepbound and Olumiant data.
- The presentations are scheduled for October 8 through October 11, 2026.
Eli Lilly and Company said in a release dated October 5, 2026, that it plans to present 21 dermatology posters at the Fall Clinical Dermatology Conference. Eli Lilly and Company said the conference is scheduled for October 8 through October 11, 2026, in Las Vegas.
Market context: Market report S&P 500.
The week in figures
The available company release identifies 21 planned poster presentations but does not provide a weekly stock balance.
Chronology of the week
October 5, 2026: Eli Lilly announced its planned dermatology program for Fall Clinical 2026, including 21 poster presentations.
Dates of the coming week
The Fall Clinical Dermatology Conference is scheduled for October 8 through October 11, 2026. Planned topics include EBGLYSS data in atopic dermatitis, Taltz and Zepbound data in psoriasis and obesity, and Olumiant data in pediatric alopecia areata.
Research program
The release said 13 presentations will concern EBGLYSS, while six will examine Taltz and Zepbound used together. It also said long-term outcomes with Olumiant in pediatric patients will be presented. The company release described the program as covering atopic dermatitis, psoriasis and alopecia areata.
